You have 9 free searches left this month | for more free features.

City

Fuzhou (1)

Guangzhou (1)

Hangzhou (1)

Shanghai (1)

Condition

Advanced Pancreatic Cancer (1)

Advanced Solid Tumors (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Shanghai Junshi Bioscience Co., Ltd. (2)

Collaborator

Intervention

js107 (2)

js107 combination with toripalimab (1)

toripalimab (1)

Study Documents

Intervention Type

drug (2)

combination product (1)

Funder Type

Other (2)

Study Type

Interventional (2)

js107

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Pancreatic Cancer Trial in Shanghai (JS107, JS107 combination with Toripalimab)

Not yet recruiting

Advanced Pancreatic Cancer

JS107
JS107 combination with Toripalimab

Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center

Dec 19, 2022

Advanced Solid Tumors Trial in Fuzhou, Guangzhou, Hangzhou (JS107, Toripalimab)

Recruiting

Advanced Solid Tumors

JS107
Toripalimab

Fuzhou, Fujian, China
+2 more

Aug 14, 2022